NYMC > News and Events > NYMC in the News

Murphy Calls For State To Invest In Hudson Valley Biotech Boom

February 01, 2017

In 2014 BioInc@NYMC was launched at the Valhalla campus of New York Medical College.  Philips’ IntelliSpace Genomics, a healthcare software company that delivers real-time diagnostic information, moved onto campus at the end of 2016.  Regeneron Pharmaceuticals, located just down the road of the College, has been in existence for more than 25 years growing to more than 5,000 employees. Dr. Robert Amler, Vice President for Government Affairs and Dean of the School of Health Sciences and Practice said, “In just two years BioInc – the biotechnology incubator at New York Medical College has become a productive asset, advancing scientific discoveries and attracting investments from outside the region.  The initial investments from Empire State Development’s REDC process, as well as federal, private and university resources, have already delivered successful outcomes and the prospect of greater advances in disaster medicine, genomic-engineered drugs, and other tools to prevent and treat disease.”

NYMC Leadership: Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice president for government affairs

Source: Terrence Murphy